Investor · 1 deal
Japanese pharmaceutical company
Every published round Rohto Pharmaceutical took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Australis Scientific | Unnamed stage | Nov 2025 | $9.3m | Lead | Startup Daily, SmartCompany |
Companies Rohto Pharmaceutical has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Australis Scientific | Digital therapeutics company developing the Confidanz Smart Patch for overactive bladder … | Nov 2025 | 1 | 1 |
Fund closes reported for Rohto Pharmaceutical, as distinct from the investments it has made.
Companies Rohto Pharmaceutical has backed that another company then bought. An exit for the holding, not a deal Rohto Pharmaceutical did.
Stories naming Rohto Pharmaceutical. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Funding roundup covering four raises: Pay.com.au's $25 million round plus a $28 million secondary, Ruminant Biotech's Series A, Australis Scientific's Rohto-backed funding, and Paperly's $3 million round led by Tribe Global Ventures.